vidarabine phosphate has been researched along with Chronic Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (61.11) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gregory, PB; Kitchen, LW; Merigan, TC; Robinson, WS; Scullard, GH; Smith, CI | 1 |
| Merigan, TC; Smith, CI | 1 |
| Dusheiko, GM; Hanson, RG; Hoofnagle, JH; Jones, EA; Minuk, GY; Pappas, SC; Popper, H; Schafer, DF; Straus, SE | 1 |
| Carreño, V; Montaño, L; Torres, M | 1 |
| Lok, AS; Thomas, HC; Wilson, LA | 1 |
| Bonino, F; Brunetto, MR; Busi, C; Di Stefano, G; Fiume, L; Gervasi, GB; Mattioli, A; Piantino, P; Torrani Cerenzia, MR; Verme, G | 1 |
| Berthelot, P; Bréchot, C; Carnot, F; Driss, F; Kreis, H; Legendre, C; Pol, S; Ruet, C; Saltiel, C | 1 |
| Bonino, F; Brunetto, MR; Busi, C; De Bernardi Venon, W; Di Stefano, G; Fiume, L; Gervasi, GB; Lavezzo, B; Mattioli, A; Ponzetto, A; Torrani Cerenzia, M; Verme, G | 1 |
| Allende, H; Buti, M; Cotrina, M; Esteban, R; Guardia, J; Jardi, R; Rodriguez-Frias, F | 1 |
| Ouzan, D | 1 |
| Bruguera, M; Kanterewicz, E; Lamarca, J; Rodés, J; Viola, C | 1 |
| Bergmann, KF; Garcia, G; Gerin, JL; Gregory, PB; Merigan, TC; Robinson, WS; Smedile, A | 1 |
| Lok, AS; Novick, DM; Thomas, HC | 1 |
| Bissett, J; Eisenberg, M; Garcia, G; Mastre, B; Nair, PV; Roskamp, D; Rosno, S; Smith, CI; Waterman, K; Weissberg, JI | 1 |
| Hoofnagle, JH | 1 |
| Novick, DM | 1 |
| Lever, AM | 1 |
| Brook, MG; McDonald, JA; Petrovic, L; Scheuer, PJ; Thomas, HC | 1 |
4 review(s) available for vidarabine phosphate and Chronic Disease
| Article | Year |
|---|---|
Therapeutic approaches to chronic hepatitis B.
Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Chronic Disease; Guanine; Hepatitis B; Humans; Immunoglobulins; Interferons; Levamisole; Ribavirin; Transfer Factor; Vidarabine; Vidarabine Phosphate | 1982 |
[Treatment of chronic hepatitis B].
Topics: Acyclovir; BCG Vaccine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Interferons; Levamisole; Transfer Factor; Vidarabine; Vidarabine Phosphate | 1983 |
[Vidarabine phosphate in the treatment of active chronic hepatitis B. A confirmed hope].
Topics: Chronic Disease; Drug Tolerance; Hepatitis B; Humans; Vidarabine Phosphate | 1992 |
Treatment of the chronic hepatitis B virus carrier state.
Topics: Arabinonucleotides; Carrier State; Chronic Disease; Hepatitis B; Humans; Immune Tolerance; Interferons; Vidarabine; Vidarabine Phosphate | 1988 |
6 trial(s) available for vidarabine phosphate and Chronic Disease
| Article | Year |
|---|---|
Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection.
Topics: Adult; Arabinonucleotides; Chronic Disease; Clinical Trials as Topic; DNA-Directed DNA Polymerase; Double-Blind Method; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Interferons; Male; Random Allocation; Vidarabine Phosphate | 1982 |
Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis.
Topics: Adult; Aged; Arabinonucleotides; Blood; Chronic Disease; Clinical Trials as Topic; DNA-Directed DNA Polymerase; Fatigue; Follow-Up Studies; Hepatitis B; Hepatitis B virus; Humans; Lymphocyte Depletion; Middle Aged; Random Allocation; Vidarabine Phosphate | 1984 |
Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Arabinonucleotides; Chronic Disease; Female; Hepatitis B; Humans; Male; Middle Aged; Muscular Diseases; Nervous System Diseases; Pain; Peripheral Nervous System Diseases; Prospective Studies; Risk; Vidarabine Phosphate | 1984 |
Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
Topics: Adult; Chronic Disease; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Humans; Interferons; Liver; Male; Middle Aged; Vidarabine Phosphate | 1996 |
Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial.
Topics: Adult; Arabinonucleotides; Chronic Disease; Clinical Trials as Topic; Combined Modality Therapy; Double-Blind Method; Female; Hepatitis B; Hepatitis B virus; Hepatitis, Chronic; Humans; Interferon Type I; Liver Cirrhosis; Male; Nervous System Diseases; Random Allocation; Vidarabine Phosphate | 1987 |
Histological improvement after anti-viral treatment for chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Arabinonucleotides; Biopsy; Child; Chronic Disease; Clinical Trials as Topic; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Humans; Interferon Type I; Male; Middle Aged; Random Allocation; Vidarabine Phosphate | 1989 |
8 other study(ies) available for vidarabine phosphate and Chronic Disease
| Article | Year |
|---|---|
Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
Topics: Adult; Aged; Chronic Disease; Female; Hepatitis B; Hepatitis B virus; Humans; Male; Middle Aged; Serum Albumin; Vidarabine Phosphate; Virus Replication | 1994 |
Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study.
Topics: Adult; Biopsy; Carrier State; Chronic Disease; DNA, Viral; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver; Male; Pilot Projects; Time Factors; Vidarabine Phosphate | 1993 |
Adenine arabinoside monophosphate coupled to lactosaminated human albumin administered for 4 weeks in patients with chronic type B hepatitis decreased viremia without producing significant side effects.
Topics: Adult; Antiviral Agents; Chronic Disease; DNA, Viral; Female; Hepatitis B; Humans; Male; Middle Aged; Serum Albumin; Vidarabine Phosphate; Viremia | 1996 |
Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.
Topics: Arabinonucleotides; Chronic Disease; Female; Hepatitis B Surface Antigens; Humans; Liver Cirrhosis; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; Vidarabine Phosphate | 1990 |
Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
Topics: Acute Disease; Adult; Arabinonucleotides; Carrier State; Chronic Disease; Hepatitis B Surface Antigens; Hepatitis D; Humans; Male; Vidarabine Phosphate | 1990 |
Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease.
Topics: Adult; Aspartate Aminotransferases; Carrier State; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Homosexuality; Humans; Immunity, Cellular; Interferon Type I; Liver Diseases; Male; Vidarabine; Vidarabine Phosphate | 1985 |
Antiviral treatment of chronic type B hepatitis.
Topics: Antiviral Agents; Chronic Disease; Combined Modality Therapy; Hepatitis B; Hepatitis B virus; Humans; Interferon Type I; Vidarabine; Vidarabine Phosphate; Virus Replication | 1987 |
Chronic hepatitis B and adenine arabinoside monophosphate (Ara-AMP)
Topics: Arabinonucleotides; Chronic Disease; Female; Hepatitis B; Homosexuality; Humans; Male; Vidarabine Phosphate | 1988 |